Position in KRYS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$55,124,606
+$18,049,230 QoQ
Shares Held
148,316
+3.3% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 419 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Derivatives in KRYS
reported options exposure · as of Jun 30, 2026CallValue
$892,008
CallShares
2,400
PutValue
$4,199,871
PutShares
11,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. KRYS ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in KRYS
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,199,871 | 11,300 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $892,008 | 2,400 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $55,124,606 | 148,316 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $37,075,376 | 143,525 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $4,158,952 | 16,100 | Put | Defined | 2026-05-05 | |
| 2025-12-31 | $39,346,550 | 159,595 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $26,214,705 | 148,500 | Put | Defined | 2025-11-13 | |
| 2025-09-30 | $22,979,438 | 130,173 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,175,412 | 52,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $13,366,609 | 97,240 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,625,754 | 81,119 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,686,520 | 100,131 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,612,966 | 36,329 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,244,023 | 28,556 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,079,411 | 51,028 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,816,084 | 30,760 | Shares | Defined | 2024-02-09 | |
| 2023-06-30 | $1,316,875 | 11,217 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,251,926 | 28,128 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,376,593 | 42,623 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $11,430 | 164 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,039,660 | 15,834 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,863,977 | 58,070 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $128,218 | 1,833 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,217,693 | 23,323 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $136,544 | 2,008 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,880,294 | 37,387 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $847,740 | 14,129 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $513,887 | 11,937 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,224 | 271 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $726,864 | 16,810 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||